Osborne Clarke acts for Red Lions, lead investor in the equity crowdfunding of Kiunsys
Osborne Clarke advised Red Lions SpA, the Lead Investor in the equity crowdfunding of Kiunsys, one of the largest operations of its type carried out to date in Italy with over 505.000€ collected over the StarsUp platform, the first portal authorised by Consob for the online collection of risk capital by innovative start-ups.
CMS has advised on the initial public offering of Wittchen S.A. (a leading Polish retailer of luxury accessories and leather goods selling luxury footwear, leather clothing and travel accessories) and the introduction of its shares to trading on the Warsaw Stock Exchange. The company operates on the Polish market for luxury accessories and leather goods. The value of the IPO totalled more than PLN 55 million, of which PLN 27.2 million was obtained through the issue of new shares for the realisation of strategic objectives.
Slaughter and May acted for International Airlines Group (IAG) on the launch of its offer of two tranches of senior unsecured bonds convertible into ordinary shares of IAG.
The aggregate offer size was fixed at EUR 1,000 million and the first tranche due 2020 will have a principal amount of EUR 500 million. The second tranche, due 2022, will also have a principal amount of EUR 500 million.
Inte Freshfields Bruckhaus Deringer has advised a consortium of underwriters on the HKD$6.28bn (US$811m) IPO of China International Capital Corporation Limited (CICC).
Trading in CICC commenced on the Hong Kong Stock Exchange on 9 November.
Originally established in 1995, CICC is one of China’s leading investment banks.
Freshfields advised the consortium of underwriters, led by China International Capital Corporation Hong Kong Securities Limited, and advised on both the Hong Kong and US aspects of the listing.
Ashurst advised the bank consortium comprising ODDO SEYDLER BANK AG (ODDO SEYDLER) and Banca IMI on the initial public offering (IPO) of Steilmann SE, one of the largest apparel companies in Germany, in the regulated market (Prime Standard) of the Frankfurt Stock Exchange. ODDO SEYDLER acted as Global Coordinator and, together with Banca IMI, as Joint Bookrunners.
DLA Piper advised Perseroan (Persero) PT Aneka Tambang Tbk ("ANTAM") (IDX: ANTM; ASX: ATM), the Republic of Indonesia's leading metals and mining company, on its landmark Rp5.9 trillion (US$393 million) rights issue. The transaction, the largest equity issue by an Indonesian mining company since 2010, was oversubscribed and the new shares were allotted on 02 November 2015.
IPO is the largest by an Indian company since 2012 and the first by an airline in India since 2006.
Thommessen acted in the establishment and IPO of Skandiabanken ASA.
Skandiabanken ASA is a Norwegian pure digital bank that offers a comprehensive range of financial products and services to individuals and households in Norway within payments and card services, deposit-based savings, investment products, long-term loans and short-term loans. The bank has no branches and all products and services are offered directly through the digital platform which is available on a broad range of user devices.
King & Wood Mallesons has advised Guangzhou Evergrande Taobao Football Club Co., Ltd. (Evergrande Taobao) on its listing on the New Third Board, a securities exchange for small and medium-sized entities (Stock Code: 834338). The groundbreaking listing of Evergrande Taobao on the New Third Board is unprecedented for football clubs in China, standing out as the No. 1 football IPO in Asia, which would inject capital and vigor into the sporting industry in China.
DLA Piper has advised the Austrian biotech company Panoptes Pharma on a recent capital increase. For the successfully closed financing round, aws Gründerfonds has become a shareholder.
The Vienna based biotech company Panoptes Pharma is focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Among their greatest achievements is PP-001, a selective anti-inflammatory small molecule compound, which has demonstrated efficacy in a variety of preclinical models in ophthalmology.